A West Wales-based company has won US approval for device-based treatment of depression, which is excellent news for taking academic findings into a clinical setting.
Clinical depression, or major depressive disorder (MDD), is a period of severe low mood and lack of motivation. Current treatments for MDD include cognitive therapy or drug-based treatments.
Now, MagStim, based in Carmarthenshire, has been granted approval in the USA for a device which aims to treat MDD using pulses of magnetic energy.
In this article, published at The Guardian, Lecturer Dr Nick Davis explains how the treatment works.
- Monday 18 May 2015 09.44 GMT
- Wednesday 27 May 2015 09.56 GMT
- Simon Dymond